The Squeeze on Tweed's Cannabis Extracts License
We are pleased to announce to our customers that we have received authorization from Health Canada to begin the production of cannabis extracts.
Tweed will use preeminent pharmaceutical grade extraction methods to produce purified cannabis derivatives.
“Our customers have come to expect the best from Tweed’s product lines,” said Bruce Linton, the Company’s Chairman and CEO. “The major advantage that comes with commercial scale is that you can provide products to customers that they couldn’t make themselves at home.”
We’ve been working hard on developing our new line of cannabis extracts, and as always have focused on having a variety of strain specific products available from the outset.
In addition to this license, we have also received approval on new state of the art drying, trimming, processing, and extraction rooms – ensuring we can maintain quality while we increase production.
We look forward to keeping you up to date as we begin to roll out our newline of extracts, providing our customers with even more products to choose from.
Here’s to future growth.
← Prev Next →
other stories you may be interested in
without your home
Hi, Yesterday, the Government of Canada announced that regulations governing medical marijuana would be amended, as expected, by August 24th, 2016, and that the majority of the previously repealed Marihuana Medical Access Regulations (MMAR) would form a part of an interim system, introduced to satisfy the requirements set out by the courts in the truncated timeline the government was given to respond...
Balconies to showcase new material at Shindig
When Liam Jaeger heard his band was playing Tweed, his first thought was to plan travel to the small Ontario town of the same name as Canada’s largest pot producer...
August Strain of the Month-Birds Eye
Few strains have as rich a history as Birds Eye...